Gaudium IVF IPO Day 3 Subscription Update: The initial public offering continues to see sustained demand from retail and non-institutional investors on the last day of bidding. Participation from qualified institutional buyers also picked up on the last day of bidding.
NPS data on returns across E,C and G schemes of NPS Tier I category indicate that no single fund manager leads across all categories
Motilal Oswal is bullish on Mphasis recommended buy rating on the stock with a target price of Rs 3400 in its research report dated February 23, 2026.